TD Cowen Reaffirms “Hold” Rating for Enhabit (NYSE:EHAB)

Enhabit (NYSE:EHAB)‘s stock had its “hold” rating reiterated by investment analysts at TD Cowen in a report issued on Friday, Marketbeat reports. They presently have a $13.80 price objective on the stock, up from their previous price objective of $12.00. TD Cowen’s price objective points to a potential upside of 1.32% from the stock’s current price.

A number of other research analysts have also weighed in on the stock. Wolfe Research set a $12.00 price target on shares of Enhabit in a research note on Thursday, January 8th. Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a “buy” rating in a research report on Tuesday, January 13th. Oppenheimer cut shares of Enhabit from an “outperform” rating to a “market perform” rating in a research report on Monday, February 23rd. UBS Group reaffirmed a “neutral” rating and issued a $13.80 target price (up from $12.00) on shares of Enhabit in a research note on Tuesday, February 24th. Finally, Citigroup reiterated a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Two investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $13.57.

Enhabit Stock Up 0.1%

Shares of Enhabit stock opened at $13.62 on Friday. The company has a market capitalization of $689.31 million, a P/E ratio of -151.33 and a beta of 1.56. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.63 and a quick ratio of 1.58. The business has a 50-day moving average of $11.13 and a two-hundred day moving average of $9.38. Enhabit has a 1 year low of $6.47 and a 1 year high of $13.64.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, meeting the consensus estimate of $0.14. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%.The business had revenue of $270.40 million for the quarter, compared to analysts’ expectations of $270.56 million. As a group, equities analysts predict that Enhabit will post 0.22 EPS for the current year.

Institutional Investors Weigh In On Enhabit

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Osaic Holdings Inc. boosted its position in Enhabit by 337.5% during the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock valued at $25,000 after purchasing an additional 2,018 shares during the last quarter. State of Alaska Department of Revenue acquired a new position in shares of Enhabit during the 3rd quarter worth approximately $27,000. Tower Research Capital LLC TRC raised its stake in shares of Enhabit by 82.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock worth $44,000 after purchasing an additional 2,059 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Enhabit by 523.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company’s stock valued at $56,000 after buying an additional 4,865 shares during the last quarter. Finally, Simplex Trading LLC grew its stake in shares of Enhabit by 69.8% in the fourth quarter. Simplex Trading LLC now owns 8,115 shares of the company’s stock valued at $75,000 after buying an additional 3,336 shares in the last quarter.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.